Introduction & Demographics

Immunotherapy is an important emerging therapy in the treatment of malignant disease. ISOPP recognizes and supports the contributions of pharmacists in providing safe and effective care to patients receiving treatment with immunotherapy. ISOPP is committed to developing and defining the role of pharmacists in this field. ISOPP has established the Immunotherapy Task Force to identify current and ongoing educational and professional needs of pharmacy professionals and to develop a White Paper on the role of the oncology pharmacist in immunotherapy. To this end, the ISOPP Immunotherapy Task Force has commissioned a survey to establish current practices across the globe to help identify and respond to the needs of ISOPP members. 

This survey is anonymous, and the response will be collated and summarized. A report of the responses will be written, and summary will be shared with ISOPP members.
 
 

Question Title

* 2. What system of health care is predominant in your country? (Choose one)

Question Title

* 3. Are you a: (Choose one)

Question Title

* 4. How would you describe your primary practice setting? (Choose one)

Question Title

* 5. How would you best describe your practice? (Choose one)

T